Tevogen Bio Holdings Inc. (NASDAQ: TVGN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TEVOGEN BIO HOLDINGS INC.

Tevogen Bio Holdings Inc. (NASDAQ: TVGN)
Listen to this Section


$9.28
+0.2200 ( +2.43% ) 0.1K

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Market Data


Open $9.28
Previous Close $9.06
Volume 0.1K
Market Cap $37.94M
Day Range $9.00 - $9.00
52 Week Range $4.14 - $75.50
Shares Outstanding 4.19M
Change % +2.43%
Net Change ▲ 0.2200
Insider Ownership -0.23%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2024
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 5,607.32

Date Type Amount Purchased Purchaser
2024-06-13 Buy 3000.00 Desai Kirti
2024-06-07 Buy 2607.32 Saadi Ryan H.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 69 Nov 14, 2025
8-k 8K-related 13 Sep 26, 2025
4 Insider transactions 1 Aug 18, 2025
10-q Quarterly Reports 67 Aug 14, 2025
8-k 8K-related 13 Jul 10, 2025
8-k 8K-related 16 Jul 03, 2025
4 Insider transactions 1 Jul 01, 2025
4 Insider transactions 1 Jul 01, 2025
4 Insider transactions 1 Jul 01, 2025
4 Insider transactions 1 Jul 01, 2025

Latest News


× Before browsing our site, please accept our cookies policy